DK1469741T3 - Fremgangsmåde til ekstraktion, oprensning og enzymatisk modifikation af soja 7S globulin alfa'-underenhed til anvendelse som hypocholesterolæmisk middel - Google Patents

Fremgangsmåde til ekstraktion, oprensning og enzymatisk modifikation af soja 7S globulin alfa'-underenhed til anvendelse som hypocholesterolæmisk middel

Info

Publication number
DK1469741T3
DK1469741T3 DK03706387T DK03706387T DK1469741T3 DK 1469741 T3 DK1469741 T3 DK 1469741T3 DK 03706387 T DK03706387 T DK 03706387T DK 03706387 T DK03706387 T DK 03706387T DK 1469741 T3 DK1469741 T3 DK 1469741T3
Authority
DK
Denmark
Prior art keywords
subunit
soy
extraction
purification
enzymatic modification
Prior art date
Application number
DK03706387T
Other languages
Danish (da)
English (en)
Inventor
Paolo Morazzoni
Marcello Duranti
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Application granted granted Critical
Publication of DK1469741T3 publication Critical patent/DK1469741T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23JPROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23JPROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/14Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from leguminous or other vegetable seeds; from press-cake or oil-bearing seeds
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23JPROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00Working-up of proteins for foodstuffs
    • A23J3/14Vegetable proteins
    • A23J3/16Vegetable proteins from soybean
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/185Vegetable proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/02Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/04Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
    • C12P7/06Ethanol, i.e. non-beverage
    • CCHEMISTRY; METALLURGY
    • C13SUGAR INDUSTRY
    • C13KSACCHARIDES OBTAINED FROM NATURAL SOURCES OR BY HYDROLYSIS OF NATURALLY OCCURRING DISACCHARIDES, OLIGOSACCHARIDES OR POLYSACCHARIDES
    • C13K1/00Glucose; Glucose-containing syrups
    • C13K1/06Glucose; Glucose-containing syrups obtained by saccharification of starch or raw materials containing starch
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E50/00Technologies for the production of fuel of non-fossil origin
    • Y02E50/10Biofuels, e.g. bio-diesel

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK03706387T 2002-01-29 2003-01-27 Fremgangsmåde til ekstraktion, oprensning og enzymatisk modifikation af soja 7S globulin alfa'-underenhed til anvendelse som hypocholesterolæmisk middel DK1469741T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2002MI000147A ITMI20020147A1 (it) 2002-01-29 2002-01-29 Estrazione purificazione e modificazione di polipeptidi da seme di soia
PCT/EP2003/000798 WO2003063608A1 (en) 2002-01-29 2003-01-27 A process for the extraction, purification and enzymatic modification of soy 7s globulin alpha' subunit for use as hypocholesterolemizing agent

Publications (1)

Publication Number Publication Date
DK1469741T3 true DK1469741T3 (da) 2007-02-19

Family

ID=11449014

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03706387T DK1469741T3 (da) 2002-01-29 2003-01-27 Fremgangsmåde til ekstraktion, oprensning og enzymatisk modifikation af soja 7S globulin alfa'-underenhed til anvendelse som hypocholesterolæmisk middel

Country Status (20)

Country Link
US (3) US7465467B2 (enExample)
EP (1) EP1469741B1 (enExample)
JP (1) JP4522706B2 (enExample)
KR (1) KR100991641B1 (enExample)
CN (1) CN100558243C (enExample)
AT (1) ATE341943T1 (enExample)
AU (1) AU2003208346B8 (enExample)
CA (1) CA2474106C (enExample)
CY (1) CY1107514T1 (enExample)
DE (1) DE60308994T2 (enExample)
DK (1) DK1469741T3 (enExample)
ES (1) ES2274208T3 (enExample)
IL (1) IL163225A (enExample)
IT (1) ITMI20020147A1 (enExample)
NO (1) NO327156B1 (enExample)
PL (1) PL209342B1 (enExample)
PT (1) PT1469741E (enExample)
RU (1) RU2300898C2 (enExample)
SG (1) SG152048A1 (enExample)
WO (1) WO2003063608A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6171640B1 (en) * 1997-04-04 2001-01-09 Monsanto Company High beta-conglycinin products and their use
EP1561384B1 (en) * 2002-11-12 2007-10-10 Fuji Oil Company, Ltd. Fractionated soybean protein and process for producing the same
JP4687463B2 (ja) * 2003-12-11 2011-05-25 不二製油株式会社 改良大豆7sたん白及びその製造法
JP5382840B2 (ja) * 2005-08-23 2014-01-08 特定非営利活動法人プライメイト・アゴラ サルモデルで薬効が確認された骨粗鬆症の予防又は治療剤
EP2384124B1 (en) * 2008-12-31 2015-09-16 Solae, Llc Protein hydrolysate compositions
EP2264054A1 (en) * 2009-06-17 2010-12-22 Indena S.p.A. Cloning, yeast expression, purification and biological activity of a truncated form of the soybean 7S globulin alfa ' subunit involved in Hep G2 cell cholesterol homeostasis
SI2264055T1 (sl) * 2009-06-17 2014-05-30 Indena S.P.A. Kloniranje, izraĺ˝anje v kvasovki, äśiĺ äśenje in bioloĺ ka aktivnost ekstenzijske regije alfa'podenote sojinega 7s globulina udeleĺ˝ene pri homeostazi holesterola hepg2 celice
CN101904406B (zh) * 2010-07-02 2012-07-25 山西大学 一种葵花籽多肽的制备方法和用途
CN104163767B (zh) * 2014-07-25 2017-01-18 湖北泓肽生物科技有限公司 一种氨基酸和多肽水溶性物质的纯化方法
CN114874301A (zh) * 2022-05-10 2022-08-09 吉林农业大学 不同亚基组成β-伴大豆球蛋白的制备方法及应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4409248A (en) 1981-08-10 1983-10-11 A. E. Staley Manufacturing Company Heat-gelling and foam-stabilizing enzymatically modified vegetable isolates
JPH06197788A (ja) 1993-01-06 1994-07-19 Fuji Oil Co Ltd 蛋白質の製造法
DE69700759T2 (de) * 1996-03-28 2000-05-31 Fuji Oil Co., Ltd. Verfahren zur Herstellung eines Sojaproteinhydrolysats
ATE347604T1 (de) * 1996-06-14 2006-12-15 Du Pont Suppressi0n spezifischer klassen von soja- sojasamenproteingenen
US6171640B1 (en) * 1997-04-04 2001-01-09 Monsanto Company High beta-conglycinin products and their use
US6365802B2 (en) * 1998-08-14 2002-04-02 Calgene Llc Methods for increasing stearate content in soybean oil
FR2784029B1 (fr) * 1998-10-05 2001-01-05 Pharmascience Lab Methode de prevention et/ou de traitement cosmetique des vergetures de la peau et utilisation en dermatologie
MXPA01010486A (es) * 1999-04-15 2002-03-27 Calgene Llc Secuencias de acido nucleico para proteinas implicadas en la sintesis de tocoferol.
CA2274414A1 (en) 1999-06-11 2000-12-11 Universite Laval Dietary fish protein for use in restoring normal insulin function insulin-resistant individuals
AUPQ877300A0 (en) 2000-07-13 2000-08-03 Johnson & Johnson Pacific Pty Limited Topical treatment of skin
KR101238752B1 (ko) * 2002-04-18 2013-03-06 몬산토 테크놀로지 엘엘씨 심혈관 질환의 위험성을 감소시키기 위한 오일 바디 결합 단백질 조성물 및 이의 사용 방법
EP1508573B1 (en) * 2003-08-20 2009-10-28 Seikagaku Corporation Stabilizing agent for enzymes
EP1841333A1 (en) * 2005-01-14 2007-10-10 Solae, Llc Soy protein for infant formula

Also Published As

Publication number Publication date
CN1622760A (zh) 2005-06-01
US20080261885A1 (en) 2008-10-23
NO20043186L (no) 2004-07-26
CA2474106A1 (en) 2003-08-07
US20110118182A1 (en) 2011-05-19
AU2003208346B8 (en) 2008-07-10
PT1469741E (pt) 2007-01-31
IL163225A (en) 2007-06-17
US20050164337A1 (en) 2005-07-28
NO327156B1 (no) 2009-05-04
AU2003208346A2 (en) 2003-09-02
CN100558243C (zh) 2009-11-11
DE60308994T2 (de) 2007-06-14
PL209342B1 (pl) 2011-08-31
DE60308994D1 (de) 2006-11-23
PL370294A1 (en) 2005-05-16
US7901718B2 (en) 2011-03-08
RU2004123201A (ru) 2005-10-27
KR20040077786A (ko) 2004-09-06
ATE341943T1 (de) 2006-11-15
EP1469741A1 (en) 2004-10-27
EP1469741B1 (en) 2006-10-11
RU2300898C2 (ru) 2007-06-20
CA2474106C (en) 2011-11-22
HK1073590A1 (zh) 2005-10-14
WO2003063608A1 (en) 2003-08-07
KR100991641B1 (ko) 2010-11-04
SG152048A1 (en) 2009-05-29
ITMI20020147A1 (it) 2003-07-29
AU2003208346B2 (en) 2008-03-06
JP4522706B2 (ja) 2010-08-11
ES2274208T3 (es) 2007-05-16
JP2005516043A (ja) 2005-06-02
CY1107514T1 (el) 2013-03-13
US8257758B2 (en) 2012-09-04
ITMI20020147A0 (it) 2002-01-29
US7465467B2 (en) 2008-12-16

Similar Documents

Publication Publication Date Title
DK1469741T3 (da) Fremgangsmåde til ekstraktion, oprensning og enzymatisk modifikation af soja 7S globulin alfa'-underenhed til anvendelse som hypocholesterolæmisk middel
DE60124918D1 (de) Kodon-optimierte papillomavirussequenzen
ATE323759T1 (de) Rückgewinnung eines proteins bei hohem ph-wert
MY152824A (en) Combination of hcv ns3 protease inhibitor with interferon and ribavirin.
HRP20090003T3 (en) Oligopeptides for reducing elevated blood urea concentration
DE60228847D1 (enExample)
EA200700215A1 (ru) Протеиновые гидролизаты, снижающие давление крови
DK1329462T3 (da) Fremgangsmåde til fremstilling af human serumalbumin, som inddrager opvarmningstrin
DK1532986T3 (da) Farmaceutisk sammensætning til behandling af rhinitis
AU7516498A (en) Removal of contaminants from gas streams in rayon production
BRPI0608273A2 (pt) peptìdeos para diminuição da pressão sanguìnea a partir de glicomacropeptìdeo
NO20080966L (no) Dykkerdrakt
JP2005516043A5 (enExample)
FR2855984B1 (fr) Procede de traitement de fumees
TW200517368A (en) Process
WO2006067163A3 (en) Blood pressure lowering oligopeptides in a single enzymatic step
SE0203551D0 (sv) Prothrombin purification
ITMI20022409A1 (it) Procedimento per la purificazione di 1, 4-butandiolo mononitrato.
WO2001066713A8 (en) Activation of pure prothrombin to thrombin with sodium citrate
Au et al. Differential Maturation of SUMO Precursors by SUMO-specific Protease, SENP1
BRPI0502744A (pt) processo para reduzir a atividade do ativador de pré-calicreìna (pka) em soluções de albumina purificada de origem humana e para estabilizá-la temporalmente; processo para obter albumina; e solução purificada de albumina de origem humana com baixa atividade do ativador de pré-calicreìna (pka) e com estabilidade temporal
NO984365L (no) IgAl proteasefragment som bµrerpeptid
DK0896579T3 (da) Genindvindelse af proteiner ved præcipitation ved anvendelse af lignosulfater
BR0316639A (pt) Processo para redução de emissões
PA8567901A1 (es) Procedimiento para la sintesis de cloroadenosina y metiltioadenosina